Literature DB >> 24701476

Relationship between Lipoprotein(a) and Thyroid Hormones in Hypothyroid Patients.

Ramachandran Kaliaperumal1, Ebenezer William2, Thangapaneer Selvam3, Shyam M Krishnan4.   

Abstract

BACKGROUND AND
OBJECTIVE: Changes in plasma lipid concentrations are well known metabolic consequences of thyroid dysfunction. The alterations are most prominent in hypothyroidism which is typically associated with pronounced hypercholesterolaemia and frequently with moderate hypertriglyceridaemia. In cases of hypothyroidism, how the serum Lp(a) levels are influenced by thyroid hormone remains unknown and contradictory results on the effect of thyroid hormone on serum Lp(a) levels have been reported. There is substantial evidence to suggest that elevated serum Lp(a) levels contribute significantly to the development of CHD. The present study was designed to determine the lipoprotein(a) [Lp(a)], lipid profile and thyroid hormone levels in newly diagnosed hypothyroid patients and to find any correlation that existed between Lp(a) and other parameters.
MATERIALS AND METHODS: Untreated hypothyroid (n=50) patients were included in the study. We also included 40 normal healthy subjects as controls. Lipid profile, Lp(a) and thyroid profile were estimated by using autoanalyzers.
RESULTS: The results of this study showed that levels of HDL-cholesterol were significantly decreased (p<0.001), whereas those of other lipid parameters and Lp(a) levels were found to be significantly increased (p<0.001) in hypothyroid patients as compared to those in controls. Correlation study revealed a significant positive correlation between Lp(a) and TSH levels in hypothyroid patients.
CONCLUSION: Our present findings indicated that hypothyroidism could be strongly associated with lipid abnormalities that enhanced the development of cardiovascular diseases. Also, Lp(a) and non-HDL-C should be estimated with other lipid parameters as a useful index for measuring the cardiac risk in hypothyroid patients. A recommended screening should be advised for any patient with thyroid dysfunction, especially hypothyroidism, to assess lipid abnormalities by using Lp(a) and non- HDL-C and he/she should treated at the earliest.

Entities:  

Keywords:  Cardiovascular disease; Hyperlipidaemia; Non-HDL-C

Year:  2014        PMID: 24701476      PMCID: PMC3972592          DOI: 10.7860/JCDR/2014/7817.4001

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Management of Lp(a).

Authors:  W Virgil Brown; Christie M Ballantyne; Peter H Jones; Santica Marcovina
Journal:  J Clin Lipidol       Date:  2010-07-14       Impact factor: 4.766

Review 2.  Lipoprotein(a): an emerging cardiovascular risk factor.

Authors:  Giuseppe Lippi; Giancesare Guidi
Journal:  Crit Rev Clin Lab Sci       Date:  2003-02       Impact factor: 6.250

3.  Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.

Authors:  Mitsuru Ito; Takeshi Arishima; Takumi Kudo; Eijun Nishihara; Hidemi Ohye; Sumihisa Kubota; Shuji Fukata; Nobuyuki Amino; Kanji Kuma; Ichiro Sasaki; Tetsuya Hiraiwa; Toshiaki Hanafusa; Junta Takamatsu; Akira Miyauchi
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

4.  Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

Authors:  B Cantin; F Gagnon; S Moorjani; J P Després; B Lamarche; P J Lupien; G R Dagenais
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

5.  Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism.

Authors:  C J Packard; J Shepherd; G M Lindsay; A Gaw; M R Taskinen
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

6.  Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages.

Authors:  M E Haberland; G M Fless; A M Scanu; A M Fogelman
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

7.  Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a).

Authors:  R Arem; D A Escalante; N Arem; J D Morrisett; W Patsch
Journal:  Metabolism       Date:  1995-12       Impact factor: 8.694

8.  Effect of thyroid function on concentrations of lipoprotein(a)

Authors:  H Engler; W F Riesen
Journal:  Clin Chem       Date:  1993-12       Impact factor: 8.327

9.  Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.

Authors:  F Pazos; J J Alvarez; J Rubiés-Prat; C Varela; M A Lasunción
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

10.  Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.

Authors:  Gérald Luc; Jean-Marie Bard; Dominique Arveiler; Jean Ferrieres; Alun Evans; Philippe Amouyel; Jean-Charles Fruchart; Pierre Ducimetiere
Journal:  Atherosclerosis       Date:  2002-08       Impact factor: 5.162

View more
  2 in total

1.  Oxidized LDL Is Strictly Limited to Hyperthyroidism Irrespective of Fat Feeding in Female Sprague Dawley Rats.

Authors:  Sieglinde Zelzer; Harald Mangge; Sabine Pailer; Herwig Ainoedhofer; Petra Kieslinger; Tatjana Stojakovic; Hubert Scharnagl; Florian Prüller; Daniel Weghuber; Christian Datz; Johannes Haybaeck; Barbara Obermayer-Pietsch; Christian Trummer; Johanna Gostner; Hans-Jürgen Gruber
Journal:  Int J Mol Sci       Date:  2015-05-21       Impact factor: 5.923

2.  Menopausal Impact on the Association Between Thyroid Dysfunction and Lipid Profiles: A Cross-Sectional Study.

Authors:  Yutong Han; Chuyuan Wang; Lihui Zhang; Jun Zhu; Mei Zhu; Yongze Li; Di Teng; Weiping Teng; Zhongyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-14       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.